|
1
|
Rini BI and Atkins MB: Resistance to
targeted therapy in renal-cell carcinoma. Lancet Oncol.
10:992–1000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perbal B: NOV (nephroblastoma
overexpressed) and the CCN family of genes: structural and
functional issues. Mol Pathol. 54:57–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joliot V, Martinerie C, Dambrine G, et al:
Proviral rearrangements and overexpression of a new cellular gene
(nov) in myeloblastosis-associated virus type 1-induced
nephroblastomas. Mol Cell Biol. 12:10–21. 1992.PubMed/NCBI
|
|
4
|
Chevalier G, Yeger H, Martinerie C, et al:
novH: differential expression in developing kidney and Wilms'
tumors. Am J Pathol. 152:1563–1575. 1998.PubMed/NCBI
|
|
5
|
Perbal B: The CCN family of cell growth
regulators: a new family of normal and pathologic cell growth and
differentiation regulators: lessons from the first international
workshop on CCN gene family. Bull Cancer. 88:645–649.
2001.PubMed/NCBI
|
|
6
|
Manara MC, Perbal B, Benini S, et al: The
expression of ccn3(nov) gene in musculoskeletal tumors. Am J
Pathol. 160:849–859. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perbal B: The CCN3 protein and cancer. Adv
Exp Med Biol. 587:23–40. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu C, Le AT, Yeger H, Perbal B and Alman
BAY: NOV (CCN3) regulation in the growth plate and CCN family
member expression in cartilage neoplasia. J Pathol. 201:609–615.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doghman M, Arhatte M, Thibout H, et al:
Nephroblastoma overexpressed/cysteine-rich protein 61/connective
tissue growth factor/nephroblastoma overexpressed gene-3
(NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is
down-regulated in childhood adrenocortical tumors. J Clin
Endocrinol Metab. 92:3253–3260. 2007. View Article : Google Scholar
|
|
10
|
Gupta N, Wang H, McLeod TL, et al:
Inhibition of glioma cell growth and tumorigenic potential by CCN3
(NOV). Mol Pathol. 54:293–299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gellhaus A, Dong X, Propson S, et al:
Connexin43 interacts with NOV: a possible mechanism for negative
regulation of cell growth in choriocarcinoma cells. J Biol Chem.
279:36931–36942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benini S, Perbal B, Zambelli D, et al: In
Ewing's sarcoma CCN3 (NOV) inhibits proliferation while promoting
migration and invasion of the same cell type. Oncogene.
24:4349–4361. 2005.
|
|
13
|
Liu C, Liu XJ, Crowe PD, et al:
Nephroblastoma overexpressed gene (NOV) codes for a growth factor
that induces protein tyrosine phosphorylation. Gene. 238:471–478.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maillard M, Cadot B, Ball RY, et al:
Differential expression of the ccn3 (nov) proto-oncogene in human
prostate cell lines and tissues. Mol Pathol. 4:275–280. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perbal B: Contribution of MAV-1-induced
nephroblastoma to the study of genes involved in human Wilms' tumor
development. Crit Rev Oncog. 5:589–613. 1994.PubMed/NCBI
|
|
16
|
Niu Z, Ito M, Awakura Y, et al: The
expression of NOV and WT1 in renal cell carcinoma: a quantitative
reverse transcriptase-polymerase chain reaction analysis. J Urol.
174:1460–1462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Evdokimova V, Tognon C, Ng T and Sorensen
PH: Reduced proliferation and enhanced migration: two sides of the
same coin? Molecular mechanisms of metastatic progression by YB-1.
Cell Cycle. 8:2901–2906. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CG, Leu SJ, Chen N, et al: CCN3 (NOV)
is a novel angiogenic regulator of the CCN protein family. J Biol
Chem. 278:24200–24208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM
and Lau LF: Integrin-dependent functions of the angiogenic inducer
NOV (CCN3): implication in wound healing. J Biol Chem.
280:8229–8237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukunaga-Kalabis M, Martinez G, Telson SM,
et al: Downregulation of CCN3 expression as a potential mechanism
for melanoma progression. Oncogene. 27:2552–2560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esteban-Barragán MA, Avila P,
Alvarez-Tejado M, et al: Role of the von Hippel-Lindau tumor
suppressor gene in the formation of beta1-integrin fibrillar
adhesions. Cancer Res. 62:2929–2936. 2002.PubMed/NCBI
|
